Results 51 to 60 of about 51,322 (300)

Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. [PDF]

, 2015
BackgroundToxic epidermal necrolysis (TEN) is a rare systemic allergic drug eruption with high patient mortality. Currently, no established treatments have been shown to be effective for TEN beyond supportive care.
Kim, Kyoungmi, Li, Chin Shang, Maverakis, Emanual, Patel, Falin B, Patel, Forum, Sharon, Victoria R, Wilken, Reason   +6 more
core   +4 more sources

Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study *

British Journal of Dermatology, 2020
A rising incidence and high mortality were found for bullous pemphigoid (BP) over a decade ago in the UK. Updated estimates of its epidemiology are required to understand the healthcare needs of an ageing population.
M. Persson, K. Harman, Y. Vinogradova, S. Langan, J. Hippisley-Cox, K. Thomas, S. Gran   +6 more
semanticscholar   +1 more source

Resolution in bullous pemphigoid [PDF]

Seminars in Immunopathology, 2019
AbstractPemphigoid diseases are a group of autoimmune blistering skin diseases defined by an immune response against certain components of the dermal-epidermal adhesion complex. They are prototypical, autoantibody-driven, organ-specific diseases with the emergence of inflammatory skin lesions dependent on the recruitment of immune cells, particularly ...
Christian D. Sadik, Enno Schmidt
openaire   +3 more sources

Субэпидермальные буллезные дерматозы [PDF]

, 2019
ПЕМФИГОИД БУЛЛЕЗНЫЙПЕМФИГОИД СЛИЗИСТЫХ ОБОЛОЧЕКПРИОБРЕТЕННЫЙ БУЛЛЕЗНЫЙ ЭПИДЕРМОЛИЗДИАГНОСТИКА ДИФФЕРЕНЦИАЛЬНАЯВо второй части статьи, посвященной дерматозам с субэпидермальным расположением пузырей при гистологическом исследовании, описываются буллезный ...
Катина, М. А., Тихоновская, И. В.   +1 more
core   +2 more sources

Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid

JEADV Clinical Practice, 2023
Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma, Kei Hayashi, Akemi Ishida‐Yamamoto   +2 more
doaj   +1 more source

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic non-inferiority randomised controlled trial [PDF]

, 2017
Background: Bullous pemphigoid (BP) is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline conveys acceptable short-term blister control whilst conferring long-term safety advantages ...
A Anstey, A Carmichael, A Lloyd Lavery, A M Layton, A Omerod, Adam Ferguson, Adzura Azam, Alex Waters, Andrew Ilchyshyn, Andrew J Nunn, Andrew Wright, Anna Chapman, B Walker, Bastuji-Garin, Bratton, Brick, C Barnard, C Günthert, C Thomas, Chalmers, Chalmers, Chris Bower, Chris Lovell, D'Agostino, David Gawkrodger, Diane Whitham, E Bröcker, E Veysey, Emilia Duarte-Williamson, Enno Schmidt, F Craig, Feliciani, Fenella Wojnarowska, Fiona Antony, Fivenson, G Patel, G Wong, Goon, Gudula Kirtschig, H Bell, H Malhomme, H Santander, Hofmann, Hywel C Williams, Indre Verpetinske, Ingrid Salvary, J Adams, J English, J Ingram, J Ravenscroft, J Wee, James Mason, Jane Sterling, Joanne R Chalmers, Joly, Joly, Joly, K Davies, K Hussain, K Steinbrink, Karen Gibbon, Karen Harman, Kathy Taghipour, Kirtschig, Langan, Lever, Lloyd-Lavery, M G S Dunnill, M Sticherling, M Vatve, M Walsh, M Westmoreland, Margaret Childs, Marinella Nik, Meijer, Monk, Murrell, N Hepburn, N J Levell, N van Beek, Offen, P J Hampton, R Ellis, R Gläser, R Groves, R Hügel, R R Coelho, R Rallan, R Wachsmuth, Riond, Robert Charles-Holmes, Roujeau, S Blackford, S Wahie, Sam Gibbs, Savin, Schmidt, Schulze, Shernaz Walton, Sobocinski, Taghipour, Taghipour, Thomas Luger, Thomas R Godec, V Akhras, V Lewis, V Venning, Venning, Walter Bottomley   +108 more
core   +4 more sources

Bullous Pemphygoid and Novel Therapeutic Approaches

Biomedicines, 2022
Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately.
Giovanni Marco D’Agostino, Giulio Rizzetto, Andrea Marani, Samuele Marasca, Matteo Candelora, Daisy Gambini, Helena Gioacchini, Edoardo De Simoni, Andrea Maurizi, Anna Campanati, Annamaria Offidani   +10 more
doaj   +1 more source

Correlation between bullous pemphigoid and type 2 inflammation

Pifu-xingbing zhenliaoxue zazhi, 2022
Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU, Guomin LI, Zhijun XU, Jie XU, Jinjin ZHENG, Hao FANG, Ruzeng XUE   +6 more
doaj   +1 more source

Bullous Pemphigoid-like Skin Eruption during Treatment with Rivaroxaban: A Clinical Case Study [PDF]

, 2018
Little has been documented about hypersensitivity reactions caused by treatment with rivaroxaban. This paper reports a bullous pemphigoid-like skin eruption that occurred in a 76-year-old female patient during rivaroxaban treatment.
Almeida Ribeiro, Jose, Ferreira, Cristiana, Furtado, Antonia, Oliveira, Ana, Rocha, Natividade   +4 more
core   +2 more sources

Eosinophilic dermatosis of hematologic malignancy: a case report [PDF]

, 2020
Eosinophilic dermatosis of hematologic malignancy (EDHM) is a dermatosis characterized by tissue eosinophilia that has been previously reported as insect bite-like reaction.
Almeida, FT, Brito, C, Caldas, R, Ferreira, O, Rodrigues, AP   +4 more
core